Prenatal diagnosis can be accomplished through amniocentesis and chorionic villus sampling to assess glutarate levels and GCDH enzyme activity [77, 78]
Pharmacological blockade of the GHSR1a or genetic ablation of this gene would result in decreased reward seeking behaviors
While a peptide like GHK-Cu Copper Peptide is a direct-action agent for skin remodeling, BPC 157's potential lies in its foundational, systemic approach
Dietary modifications, such as avoiding high-fat foods or lactose-containing products, may help manage this side effect
But some previous clinical trials found that people lost up to 20% of their body weight while on these GLP-1 drugs
For how these effects fit into the receptor biology, discovery, and pipeline behind the class, see the wider view of GLP-1 and metabolic disease